58. 肥大型心筋症 Hypertrophic cardiomyopathy Clinical trials / Disease details


臨床試験数 : 119 薬物数 : 163 - (DrugBank : 45) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 161

  
7 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04684290
(ClinicalTrials.gov)
June 30, 202116/11/2020Surgical Septal Myectomy vs Percutaneous Transluminal Alcohol Septal Ablation in Patients With Hypertrophic Obstructive CardiomyopathySurgical Septal Myectomy Versus Percutaneous Transluminal Alcohol Septal Ablation in Patients With Hypertrophic Obstructive CardiomyopathyHypertrophic CardiomyopathyProcedure: Alcohol Septal Ablation;Procedure: Surgical Septal MyectomySt. Antonius HospitalErasmus Medical CenterRecruiting40 Years75 YearsAll100N/ANetherlands
2ChiCTR2000041464
2021-01-012020-12-26The efficacy after alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: a retrospective study based on medical recordsThe efficacy after alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy hypertrophic obstructive cardiomyopathyalcohol septal ablation group vs medical treatment group :Nil;Beijing Anzhen Hospital, Capital Medical UniversityNULLRecruiting1880Bothalcohol septal ablation group vs medical treatment group :200;China
3ChiCTR2000033626
2020-06-012020-06-07Endocardial Radiofrequency Septal Ablation Versus Alcohol Septal Ablation for Hypertrophic Obstructive CardiomyopathyEndocardial Radiofrequency Septal Ablation Versus Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: a Randomized, Controlled, Open-Label Non-Inferiority Study Hypertrophic Obstructive Cardiomyopathydiofrequency ablation:radiofrequency ablation;Alcohol Ablation:Alcohol Septal Ablation;Sir Run Run Shaw Hospital, Zhejiang University School of MedicineNULLRecruiting1875Bothdiofrequency ablation:40;Alcohol Ablation:40;China
4NCT04133532
(ClinicalTrials.gov)
March 5, 202016/10/2019Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic CardiomyopathyEffect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic CardiomyopathyHypertrophic CardiomyopathyDrug: MetoprololUniversity Hospital, MotolNULLRecruiting18 Years75 YearsAll50Phase 4Czechia
5NCT04066777
(ClinicalTrials.gov)
May 29, 201922/8/2019The Effect of TASH in Patients With HOCMThe Effect of Alcohol Septal Ablation Theraphy on Left Ventricular Function and Invasive Hemodynamics at Rest and During Exercise in Patients With Hypertrophic Obstructive CardiomyopathyHypertrophic Obstructive CardiomyopathyProcedure: alcohol septal ablationSteen Hvitfeldt PoulsenNULLRecruiting18 YearsN/AAll24N/ADenmark
6NCT02674958
(ClinicalTrials.gov)
May 20166/1/2016Mobilization of Endothelial Progenitor Cells and AspirinMobilization of Endothelial Progenitor Cells Following Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Randomized Controlled Trial of AspirinHypertrophic Obstructive CardiomyopathyDrug: AspirinOttawa Heart Institute Research CorporationNULLRecruiting18 Years80 YearsAll20Phase 3Canada
7NCT00035386
(ClinicalTrials.gov)
April 20022/5/2002Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot StudyTrans-Right Ventricular Approach to Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Feasibility StudyHypertrophic CardiomyopathyProcedure: trans-right ventricular alcohol septal ablation (TRVASA)National Heart, Lung, and Blood Institute (NHLBI)NULLCompletedN/AN/ABoth12Phase 2United States